Similarly, research for breast cancer indicated that SLC25A8 overexpression might directly affect the mitochondrial membrane potential of tumor cells, inhibit cell apoptosis, and promote tumor metastasis through the TGF-β pathway, resulting in the poor prognosis [45]. The gene discussed is UCP2; the disease is neoplasm.